EndoStim, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EndoStim, Inc. - overview
Location
Dallas, TX, US
Primary Industry
Medical Devices & Equipment
About
EndoStim, Inc. specializes in developing innovative neurostimulation therapies for patients suffering from drug-refractory gastroesophageal reflux disease (GERD), aiming to improve their health and quality of life. EndoStim, Inc. is dedicated to addressing GERD through its pioneering EndoStim System, which employs neurostimulation to treat the condition.
The company is headquartered in Dallas, US. Founded by Virender Sharma, the firm has seen strategic pivots throughout its development. It has engaged in 11 deals, with the latest funding round being VENTURE DEBT, raising USD 2. 81 mn and bringing the total funds raised to USD 12.
15 mn. The current CEO is Eric Goorno. EndoStim focuses on the EndoStim System, a neurostimulation treatment designed to deliver mild electrical signals to strengthen the lower esophageal sphincter (LES) in GERD patients. This innovative treatment strategy aims to provide lasting relief from reflux symptoms, primarily targeting patients in North America and Europe.
The primary customers include healthcare providers, gastroenterologists, and hospitals that facilitate this treatment, addressing chronic pain and discomfort for patients. EndoStim generates revenue through the direct sale of its neurostimulation devices, specifically the EndoStim System, to healthcare institutions. Sales are facilitated through negotiated pricing agreements based on the volume of products ordered, involving one-time costs for the devices and potential ongoing service agreements for support and maintenance. This transaction structure plays a critical role in the company's revenue model.
EndoStim, Inc. ceased its operations due to lack of funding.
Current Investors
Wellington Partners, Gimv, Endeavour Vision
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.endostim.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.